Article

An oral protein cocktail therapeutic for <i>C. difficile</i> infection

2021-12-22

Abstract excerpt

Here we show that transgenic spirulina may solve key challenges of developing effective monoclonal protein therapeutics for diseases afflicting gastrointestinal (GI) tissues. We describe, as a paradigm for this novel approach, LMN-201: an investigational four-component treatment for Clostridioides difficile (C. difficile) infection comprising four monoclonal protein therapeutics produced and delivered within spiru...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 36379bbd-9ccb-5017-8ee3-d1aeca88901f
DOI: 10.1101/2021.12.21.473715

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

An oral protein cocktail therapeutic for <i>C. difficile</i> infectionDOI 10.1101/2021.12.21.473715Read

ENGINEERING AND PRECLINICAL EVALUATION OF DRIED FOOD-FORMULATED YEAST-SECRETED ANTIBODIES AS PERI-EXPOSURE PROPHYLAXIS AGAINST CLOSTRIDIOIDES DIFFICILE DISEASESemantic proximity Read

Orally available designed miniproteins inhibit enterotoxigenic <i>Bacteroides fragilis</i> pathology by blocking toxin receptor bindingSemantic proximity Read

Engineered antibodies targeted to bacterial surface integrate effector functions with toxin neutralization to provide superior efficacy against bacterial infectionsSemantic proximity Read

<i>Caenorhabditis elegans</i> model for <i>in vivo</i> screening of human gut microbiota mediated colonization and colonization resistance against <i>Clostridioides difficile</i>Semantic proximity Read

Species richness determines <i>C. difficile</i> invasion outcome in synthetic human gut communitiesSemantic proximity Read

A monoclonal antibody collection for <i>C. difficile</i> typingSemantic proximity Read

citrOgen: a synthesis-free polysaccharide and protein antigen-presentation to antibody-induction platformSemantic proximity Read

Depletion of microbiome-derived molecules in the host using <i>Clostridium</i> geneticsSemantic proximity Read

<i>In situ</i> deposition of nanobodies by an engineered commensal microbe promotes survival in a mouse model of enterohemorrhagic <i>E. coli</i>Semantic proximity Read

Nanobodies against C. difficile TcdA and TcdB reveal unexpected neutralizing epitopes and provide a toolkit for toxin quantitation in vivoSemantic proximity Read

New class of precision antimicrobials redefines role of Clostridium difficile S-layer in virulence and viability.Semantic proximity Read

Selection of Nanobodies that Block the Enzymatic and Cytotoxic Activities of the Binary Clostridium Difficile Toxin CDTSemantic proximity Read